Technology | March 23, 2015

FDA Approves Biotronik Eluna Pacemaker System with Full-Body ProMRI Technology

Single- and dual-chamber pacemakers give patients access to MRI scans

Biotronik, Eluna, ProMRI, FDA

March 23, 2015 — Biotronik announced that the U.S. Food and Drug Administration (FDA) has approved its ProMRI Eluna pacemaker system. Biotronik ProMRI technology allows patients to undergo full-body magnetic resonance imaging (MRI) scans with both single-chamber (SR-T) and dual-chamber (DR-T) Eluna pacemakers when implanted with Setrox pacing leads.

Until now, patients with single-chamber pacemakers have not been able to access cardiac or thoracic MRI scans. The Eluna joins Biotronik’s portfolio of pacemakers approved for use with all 1.5 T MRI scans. Magnetic resonance imaging improves diagnostic capabilities for many medical conditions like chronic neck or lower back pain, soft tissue masses and stroke symptoms that cannot be adequately examined by X-ray or computerized tomography (CT).

“Due to safety concerns, most pacemakers are currently not approved for use in the MRI environment, limiting patients’ treatment options,” said Theofanie Mela, M.D., electrophysiologist at Massachusetts General Hospital in Boston, Massachusetts, and investigator for the Biotronik ProMRI study. “MR conditional systems are necessary, and giving patients better access to diagnostic options will allow for better treatment.”

There are more than 6.5 million pacemaker patients worldwide, with an additional million patients receiving new implants each year. Until recently, patients with a pacemaker or implantable cardioverter defibrillator (ICD) were denied MRI scans due to concern that the strong magnetic fields and radio waves created by an MRI scanner could have a negative effect on both the implanted device and the patient.

Eluna pacemakers are available with Biotronik Home Monitoring, which allows physicians to manage their patients’ status through early detection of clinical episodes and device events.

For more information: www.biotronik.com

Related Content

Greater Left Ventricular Mass Increases Risk of Heart Failure
News | Magnetic Resonance Imaging (MRI) | October 21, 2019
Elevated left ventricular mass, known as left-ventricular hypertrophy, is a stronger predictor of coronary artery...
Heart MRI example. An example of a cardiac MRI exam showing perfusion defects in the heart muscle, amount of infarct and edema and a score for myocardial salvage which can help determine if revasularization will help restore heart function.

A example of a cardiac MRI exam showing perfusion defects in the heart muscle, amount of infarct and edema and a score for myocardial salvage, which can help determine if revasularization will restore heart function following a heart attack.

News | Magnetic Resonance Imaging (MRI) | October 07, 2019
October 7, 2019 – A recent study published in the New England Journal of Medicine supports the use of
Machine Learning Could Offer Faster, More Precise Cardiac MRI Scan Results
News | Magnetic Resonance Imaging (MRI) | September 25, 2019
Cardiac magnetic resonance imaging (MRI) analysis can be performed significantly faster with similar precision to...
Haojie Wang, M.D., director of advanced cardiovascular MRI and a member of the heart valve clinic at Baylor Scott White Heart Hospital, Dallas. His hospital installed a dedicated cardiac Siemens 1.5T MRI scanner in 2018 because MRI offers soft tissue visualization not available on CT or ultrasound.

Haojie Wang, M.D., director of advanced cardiovascular MRI and a member of the heart valve clinic at Baylor Scott White Heart Hospital, Dallas. His hospital installed a dedicated cardiac Siemens 1.5T MRI scanner in 2018 because MRI offers soft tissue visualization not available on CT or ultrasound.

Feature | Magnetic Resonance Imaging (MRI) | September 06, 2019 | Jeff Zagoudis, Associate Editor
Traditionally, computed tomography (CT) and ultrasound have been the workhorse imaging modalities in the world of car
Displacement comparison at the end-systolic frame and final frame

Displacement comparison at the end-systolic frame and final frame. The three patients (V6, V10, V16) with different left-ventricle walls are shown. Point-to-surface distance is a measure to estimate the distance of a point from the reference surface. Image courtesy of WMG, University of Warwick

News | Magnetic Resonance Imaging (MRI) | August 28, 2019
A new 3-D magnetic resonance imaging (MRI) computing technique developed by scientists in WMG at the University of...
FDA Issues Draft Guidance on Medical Device Safety in MRI Environment
News | Magnetic Resonance Imaging (MRI) | August 01, 2019 | Jeff Zagoudis, Associate Editor
The U.S. Food and Drug Administration (FDA) issued a new draft guidance titled Testing and Labeling Medical Devices for...
360 Photos | Magnetic Resonance Imaging (MRI) | May 17, 2019
This is a dedicated cardiac Siemens 1.5T MRI system installed at the...
Miami Cardiac and Vascular Institute Implements Philips Ingenia Ambition 1.5T MRI
News | Magnetic Resonance Imaging (MRI) | May 17, 2019
Miami Cardiac & Vascular Institute announced the implementation of Philips’ Ingenia Ambition 1.5T MR, the world’s...
Circle Cardiovascular Imaging and Galgo Medical Enter Distribution and Joint Development Agreement
News | Magnetic Resonance Imaging (MRI) | February 14, 2019
Circle Cardiovascular Imaging and Galgo Medical recently announced an agreement for distribution and joint development...
FDA Clears Magnetom Lumina 3T MRI From Siemens Healthineers
Technology | Magnetic Resonance Imaging (MRI) | January 30, 2019
The U.S. Food and Drug Administration (FDA) has cleared the Magnetom Lumina 3 Tesla (3T) magnetic resonance imaging (...
Overlay Init